Emmerich J - Search Results

1

Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis.

Smadja DM, Bièche I, Silvestre JS, Germain S, Cornet A, Laurendeau I, Duong-Van-Huyen JP, Emmerich J, Vidaud M, Aiach M, Gaussem P. Smadja DM, et al. Among authors: emmerich j. Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2137-43. doi: 10.1161/ATVBAHA.108.168815. Epub 2008 Sep 25. Arterioscler Thromb Vasc Biol. 2008. PMID: 18818419 Clinical Trial.

2

Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia.

Duong Van Huyen JP, Smadja DM, Bruneval P, Gaussem P, Dal-Cortivo L, Julia P, Fiessinger JN, Cavazzana-Calvo M, Aiach M, Emmerich J. Duong Van Huyen JP, et al. Among authors: emmerich j. Mod Pathol. 2008 Jul;21(7):837-46. doi: 10.1038/modpathol.2008.48. Epub 2008 May 16. Mod Pathol. 2008. PMID: 18487998 Free article. Clinical Trial.

3

Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells.

Smadja DM, Bièche I, Susen S, Mauge L, Laurendeau I, d'Audigier C, Grelac F, Emmerich J, Aiach M, Gaussem P. Smadja DM, et al. Among authors: emmerich j. J Cell Mol Med. 2009 Aug;13(8B):2534-2546. doi: 10.1111/j.1582-4934.2008.00429.x. Epub 2008 Jul 23. J Cell Mol Med. 2009. PMID: 18657231 Free PMC article.

4

Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.

Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P. Smadja DM, et al. Among authors: emmerich j. Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):551-9. doi: 10.1161/ATVBAHA.110.220624. Epub 2010 Dec 9. Arterioscler Thromb Vasc Biol. 2011. PMID: 21148423 Clinical Trial.

5

Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia.

Smadja DM, Duong-van-Huyen JP, Dal Cortivo L, Blanchard A, Bruneval P, Emmerich J, Gaussem P. Smadja DM, et al. Among authors: emmerich j. Cytotherapy. 2012 Feb;14(2):232-9. doi: 10.3109/14653249.2011.627917. Epub 2011 Oct 31. Cytotherapy. 2012. PMID: 22040109 Clinical Trial.

6

Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy.

Smadja DM, Cornet A, Emmerich J, Aiach M, Gaussem P. Smadja DM, et al. Among authors: emmerich j. Cell Biol Toxicol. 2007 Jul;23(4):223-39. doi: 10.1007/s10565-007-0177-6. Epub 2007 Mar 16. Cell Biol Toxicol. 2007. PMID: 17370127 Review.

7

The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers.

Reny JL, Laurendeau I, Fontana P, Bièche I, Dupont A, Remones V, Emmerich J, Vidaud M, Aiach M, Gaussem P. Reny JL, et al. Among authors: emmerich j. Thromb Haemost. 2004 Feb;91(2):248-54. doi: 10.1160/TH03-09-0566. Thromb Haemost. 2004. PMID: 14961150

8

Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.

Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, Blanco-Colio LM, Meilhac O. Moreno JA, et al. Among authors: emmerich j. Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1253-62. doi: 10.1161/ATVBAHA.110.203364. Epub 2010 Mar 18. Arterioscler Thromb Vasc Biol. 2010. PMID: 20299688

9

HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.

HoWangYin KY, Loinard C, Bakker W, Guérin CL, Vilar J, d'Audigier C, Mauge L, Bruneval P, Emmerich J, Lévy BI, Pouysségur J, Smadja DM, Silvestre JS. HoWangYin KY, et al. Among authors: emmerich j. Stem Cells. 2014 Jan;32(1):231-43. doi: 10.1002/stem.1540. Stem Cells. 2014. PMID: 24105925 Clinical Trial.

10

PAR-1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood.

Smadja DM, Bièche I, Emmerich J, Aiach M, Gaussem P. Smadja DM, et al. Among authors: emmerich j. J Thromb Haemost. 2006 Dec;4(12):2729-31. doi: 10.1111/j.1538-7836.2006.02208.x. J Thromb Haemost. 2006. PMID: 17100658 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters